Inactive Instrument

Birzeit Pharmaceuticals Company Stock Palestine Exchange

Equities

Pharmaceuticals

End-of-day quote Palestine Exchange
- - Intraday chart for Birzeit Pharmaceuticals Company
Sales 2021 45.47M 0 Sales 2022 47.03M 0 Capitalization 171M 0
Net income 2021 12M - Net income 2022 7M - EV / Sales 2021 2.15 x
Net cash position 2021 11.78M 0 Net cash position 2022 15.41M 0 EV / Sales 2022 3.31 x
P/E ratio 2021
9.07 x
P/E ratio 2022
21.5 x
Employees -
Yield 2021
1.77%
Yield 2022
2.27%
Free-Float 73.92%
More Fundamentals * Assessed data
Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
What does the Gotham City report say about Grifols? RE
Birzeit Pharmaceuticals Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Russian lender TCS picks payments firm BPC for Philippines expansion RE
Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Birzeit Pharmaceuticals Company Announces Cash Distribution, Payment Date Is 2019-07-01 CI
Birzeit Pharmaceuticals Company Announces Cash Distribution, Payable on June 15, 2018 CI
Birzeit Pharmaceuticals Company Reports Earnings Results for the Nine Months Ended September 30, 2014 CI
More news
Managers TitleAgeSince
Chief Executive Officer 74 84-03-31
Director of Finance/CFO - 84-11-14
Chief Tech/Sci/R&D Officer - 97-01-31
Members of the board TitleAgeSince
Director/Board Member - 20-12-31
Chief Administrative Officer 54 91-12-31
Chief Executive Officer 74 84-03-31
More insiders
Birzeit Pharmaceutical Company Ltd is a Palestine-based pharmaceutical company engaged in manufacturing and distributing generic medicines products in a variety of therapeutic fields. The Company manufactures and markets more than 300 products distributed among ten lines of production: Ampoules, Capsules, Tablets and Caplets, Syrups, Suspensions and Granules, Ophthalmic, Semi-solids, Powder vials, Suppositories and Powders. In addition to customers in the local Palestinian market, including Ministry of Health, local health care organizations, international health care organizations and programs, the Company has also presence in different export markets, mainly Algeria and East Europe. The Company also operates through its subsidiaries included Palestine Printing and Publishing Company and Midex for Medical Supplies.
More about the company